Literature DB >> 30887070

[Minimal change disease and focal segmental glomerulosclerosis].

J Müller-Deile1, H Schenk2, M Schiffer3,4.   

Abstract

Minimal change disease (MCD) or minimal change glomerulonephritis and focal segmental glomerulosclerosis (FSGS) are the two major causes of nephrotic syndrome in children and young adults. Both disease entities resemble each other and can sometimes only be discriminated on the basis of their clinical courses. MCD and FSGS display two classical examples that share a common pathophysiology in which the glomerular podocyte and the cytoskeleton of its foot processes play important roles. Therefore, the term "podocytopathy" was introduced for both diseases. In this article, we compare their differences and similarities, and summarized new data on pathophysiology and treatment. In adults, only a renal biopsy including electron microscopy allows for the discrimination of MCD and FSGS and other differential diagnoses. The identification of a primary or secondary form of the disease is based on the clinical course. Data from studies on the treatment are sparse; hence, treatment is still based on high-dose steroids followed by additional immunosuppressive agents. In secondary forms, treatment of the underlying disease is elementary.

Entities:  

Keywords:  Biopsy, kidney; Immunosuppression; Nephrotic syndrome; Podocytes; Steroids

Mesh:

Substances:

Year:  2019        PMID: 30887070     DOI: 10.1007/s00108-019-0590-y

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  56 in total

1.  B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion.

Authors:  H Dong; G Zhu; K Tamada; L Chen
Journal:  Nat Med       Date:  1999-12       Impact factor: 53.440

2.  B7-1 Is Not Induced in Podocytes of Human and Experimental Diabetic Nephropathy.

Authors:  Elena Gagliardini; Rubina Novelli; Daniela Corna; Carlamaria Zoja; Barbara Ruggiero; Ariela Benigni; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

3.  Abatacept in B7-1-positive proteinuric kidney disease.

Authors:  Nada Alachkar; Naima Carter-Monroe; Jochen Reiser
Journal:  N Engl J Med       Date:  2014-03-27       Impact factor: 91.245

4.  Deficits in sialylation impair podocyte maturation.

Authors:  Birgit Weinhold; Melanie Sellmeier; Wiebke Schaper; Linda Blume; Brigitte Philippens; Elina Kats; Ulrike Bernard; Sebastian P Galuska; Hildegard Geyer; Rudolf Geyer; Kirstin Worthmann; Mario Schiffer; Stephanie Groos; Rita Gerardy-Schahn; Anja K Münster-Kühnel
Journal:  J Am Soc Nephrol       Date:  2012-06-28       Impact factor: 10.121

5.  Removal of focal segmental glomerulosclerosis (FSGS) factor suPAR using CytoSorb.

Authors:  Heiko Schenk; Janina Müller-Deile; Roland Schmitt; Jan Hinrich Bräsen; Hermann Haller; Mario Schiffer
Journal:  J Clin Apher       Date:  2017-03-29       Impact factor: 2.821

6.  Urinary CD80 excretion increases in idiopathic minimal-change disease.

Authors:  Eduardo H Garin; Leila N Diaz; Wei Mu; Clive Wasserfall; Carlos Araya; Mark Segal; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2008-12-03       Impact factor: 10.121

7.  Minimal change nephrotic syndrome revealing solid tumors.

Authors:  A Meyrier; M Delahousse; P Callard; M Rainfray
Journal:  Nephron       Date:  1992       Impact factor: 2.847

8.  Adult minimal-change disease: clinical characteristics, treatment, and outcomes.

Authors:  Meryl Waldman; R John Crew; Anthony Valeri; Joshua Busch; Barry Stokes; Glen Markowitz; Vivette D'Agati; Gerald Appel
Journal:  Clin J Am Soc Nephrol       Date:  2007-04-11       Impact factor: 8.237

9.  Angiopoietin-like-4 and minimal change disease.

Authors:  Gabriel Cara-Fuentes; Alfons Segarra; Cecilia Silva-Sanchez; Heiman Wang; Miguel A Lanaspa; Richard J Johnson; Eduardo H Garin
Journal:  PLoS One       Date:  2017-04-25       Impact factor: 3.240

10.  A Study of Clinical Presentation and Correlative Histopathological Patterns in Renal Parenchymal Disease.

Authors:  K Ganesh; R R Nair; N V Seethalekshmy; G Kurian; A Mathew; S Sreedharan; Z Paul
Journal:  Indian J Nephrol       Date:  2018 Jan-Feb
View more
  3 in total

1.  Transition from minimal change disease to focal segmental glomerulosclerosis related to occupational exposure: A case report.

Authors:  Long Tang; Zhen Cai; Su-Xia Wang; Wen-Jing Zhao
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

Review 2.  Podocytopathies.

Authors:  Jeffrey B Kopp; Hans-Joachim Anders; Katalin Susztak; Manuel A Podestà; Giuseppe Remuzzi; Friedhelm Hildebrandt; Paola Romagnani
Journal:  Nat Rev Dis Primers       Date:  2020-08-13       Impact factor: 52.329

3.  Serum IgE Levels Are Associated With the Prognosis of Minimal Change Disease.

Authors:  Heng Li; Lefeng Wang; Xiayu Li; Wenqing Chen; Ying Zhang; Jianghua Chen
Journal:  Front Immunol       Date:  2022-03-17       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.